Skip to menu Skip to content Skip to footer

2025

Other Outputs

The evaluation of the extended post care support program: final report

Povey, J., Venables, J., Garvey, G., Clague, D., O’Donnell, A., Rhodes, M., Jeong, J., Kennedy, E., Edmunds, K., Chinaka, C., Garvey, D., Johnstone, M., Carr, K., Marrington, S., Blackman, N., Carson, C., Condon, P., Djuricic, G., Kevill, B., Knight-Arandale, H-M., McDonnell, J., McSpadden, D., Monssen, T., Tuhoro, H., Sky, E., Parsell, C., Butler, C. and Nuttall, G. (2025). The evaluation of the extended post care support program: final report. Brisbane, QLD, Australia: Institute for Social Science Research, The University of Queensland.

The evaluation of the extended post care support program: final report

2025

Journal Article

The cost-utility of targeted germline BRCA testing in localised prostate cancer followed by cascade testing first-degree relatives with pathogenic variants

Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Smith, David P., Fairbairn, David, Horvath, Lisa G. and Tuffaha, Haitham (2025). The cost-utility of targeted germline BRCA testing in localised prostate cancer followed by cascade testing first-degree relatives with pathogenic variants. Genetics in Medicine, 27 (8) 101463, 101463. doi: 10.1016/j.gim.2025.101463

The cost-utility of targeted germline BRCA testing in localised prostate cancer followed by cascade testing first-degree relatives with pathogenic variants

2025

Conference Publication

Prostate Cancer Specialist Nursing Program: A Social Return on Investment

Edmunds, Kim (2025). Prostate Cancer Specialist Nursing Program: A Social Return on Investment. ISPOR 2025 Conference, Montreal, QC Canada, 13 - 16 May 2025. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2025.04.349

Prostate Cancer Specialist Nursing Program: A Social Return on Investment

2025

Conference Publication

COSA Exercise Guidelines: What is the value of implementation?

Edmunds, Kim, Wang, Yufan, Mizrahi, David, McCarthy, Sandie and Tuffaha, Haitham (2025). COSA Exercise Guidelines: What is the value of implementation?. ISPOR 2025 Conference, Glasgow, United Kingdom, 13 - 16 May 2025. New York, NY United States: Elsevier. doi: 10.1016/j.jval.2025.04.453

COSA Exercise Guidelines: What is the value of implementation?

2025

Conference Publication

Prostate cancer specialist nursing program: a social return on investment analysis of the prostate cancer specialist nursing program

Edmunds, Kim, Wang, Yufan, Sara, Sally, Riley, Bernie, Heneka, Nicole and Tuffaha, Haitham (2025). Prostate cancer specialist nursing program: a social return on investment analysis of the prostate cancer specialist nursing program. ISPOR 2025 Conference, Montreal, Canada, 13-16 May 2025.

Prostate cancer specialist nursing program: a social return on investment analysis of the prostate cancer specialist nursing program

2025

Conference Publication

COSA Exercise Guidelines: what is the value of implementation?

Edmunds, Kim, Wang, Yufan, Mizrahi, David, McCarthy, Sandie and Tuffaha, Haitham (2025). COSA Exercise Guidelines: what is the value of implementation?. ISPOR 2025 Conference, Montreal, Canada, 13-16 May 2025.

COSA Exercise Guidelines: what is the value of implementation?

2025

Journal Article

Prostate cancer specialist nursing program: A social return on investment analysis value for money of the prostate cancer specialist nursing program

Edmunds, Kim, Wang, Yufan, Sara, Sally, Riley, Bernie, Heneka, Nicole and Tuffaha, Haitham (2025). Prostate cancer specialist nursing program: A social return on investment analysis value for money of the prostate cancer specialist nursing program. Psycho-Oncology, 34 (5) e70181, 1-14. doi: 10.1002/pon.70181

Prostate cancer specialist nursing program: A social return on investment analysis value for money of the prostate cancer specialist nursing program

2025

Other Outputs

The evaluation of the Extended Post Care Support (EPCS) program: interim report

Povey J., Johnstone, M., Venables, J., Garvey, G., Clague, D., O'Donnell, A., Rhodes, M., Jeong, J., Kennedy, E., Carr, K., Edmunds, K., Garvey, D., Marrington, S., Blackman, N., Carson, C., Kolesnikova, I., Eastwell, L., Condon, P., Djuricic, G., Kevill, B., Knight-Arandale, H-M., McDonnell, J., McSpadden, D., Monssen, T., Tuhoro, H., Sky, E., Parsell, C., Butler, C. and Nuttall, G. (2025). The evaluation of the Extended Post Care Support (EPCS) program: interim report. Brisbane, QLD Australia: The University of Queensland.

The evaluation of the Extended Post Care Support (EPCS) program: interim report

2025

Conference Publication

Prostate cancer specialist nursing program: a social return on investment analysis of the prostate cancer specialist nursing program.

Edmunds, Kim, Wang, Yufan, Sara, Sally, Riley, Bernie, Heneka, Nicole and Tuffaha, Haitham (2025). Prostate cancer specialist nursing program: a social return on investment analysis of the prostate cancer specialist nursing program.. 13th Health Services Research Conference, Brisbane, QLD Australia, 4-6 December 2025.

Prostate cancer specialist nursing program: a social return on investment analysis of the prostate cancer specialist nursing program.

2024

Conference Publication

The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

Teppala, S., Scuffham, P., Edmunds, K., Roberts, M., Fairbairn, D., Smith, D., Horvath, L. and Tuffaha, H. (2024). The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17-20 November 2024. New York, United States: Elsevier. doi: 10.1016/j.jval.2024.10.610

The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

2024

Journal Article

The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019

The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

2024

Conference Publication

The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

Teppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew, Fairbairn, David, Smith, David, Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons.

The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers

2024

Journal Article

Guidelines for genetic testing in prostate cancer: a scoping review

Tuffaha, Haitham, Edmunds, Kim, Fairbairn, David, Roberts, Matthew J., Chambers, Suzanne, Smith, David P, Horvath, Lisa, Arora, Shiksha and Scuffham, Paul (2024). Guidelines for genetic testing in prostate cancer: a scoping review. Prostate Cancer and Prostatic Diseases, 27 (4), 594-603. doi: 10.1038/s41391-023-00676-0

Guidelines for genetic testing in prostate cancer: a scoping review

2023

Other Outputs

(November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.

Edmunds, K., Hettiarachchi, R., Teppala, S., Shiksha, A., Madeline, O. and Tuffaha, H. (2023). (November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.. Canberra, ACT, Australia: Commonwealth of Australia.

(November 2023), MSAC Application No. 1713 – Cardiac MRI in the diagnosis of myocarditis, Department Contracted Assessment Report (DCAR). Commonwealth of Australia, Canberra, ACT.

2022

Conference Publication

Genetic testing in prostate cancer: a scoping literature review

Edmunds, Kim, Arora, Shiksha, Roberts, Matthew, Fairbairn, David, Scuffham, Paul, Smith, David, Chambers, Suzanne, Horvath, Lisa and Tuffaha, Haitham (2022). Genetic testing in prostate cancer: a scoping literature review. COSA's 49th Annual Scientific Meeting Equitable cancer care for all: Gender, identity, culture, geography, and disease should not matter, Online, 2–4 November 2022. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Genetic testing in prostate cancer: a scoping literature review

2022

Journal Article

A benefit-cost analysis of BackTrack, a multi-component, community-based intervention for high-risk young people in a rural Australian setting

Deeming, Simon, Edmunds, Kim, Knight, Alice, Searles, Andrew, Shakeshaft, Anthony P. and Doran, Christopher M. (2022). A benefit-cost analysis of BackTrack, a multi-component, community-based intervention for high-risk young people in a rural Australian setting. International Journal of Environmental Research and Public Health, 19 (16) 10273, 1-12. doi: 10.3390/ijerph191610273

A benefit-cost analysis of BackTrack, a multi-component, community-based intervention for high-risk young people in a rural Australian setting

2022

Other Outputs

Validation of Strokenomics Budget Impact Model for Stryker stent-based mechanical thrombectomy for acute ischaemic stroke

Edmunds, Kim and Tuffaha, Haitham (2022). Validation of Strokenomics Budget Impact Model for Stryker stent-based mechanical thrombectomy for acute ischaemic stroke. Brisbane, QLD Australia: The University of Queensland.

Validation of Strokenomics Budget Impact Model for Stryker stent-based mechanical thrombectomy for acute ischaemic stroke

2022

Other Outputs

Validation of a Budget Impact Model for stent-based mechanical thrombectomy for acute ischaemic stroke

Edmunds, Kim and Tuffaha, Haitham (2022). Validation of a Budget Impact Model for stent-based mechanical thrombectomy for acute ischaemic stroke. Unknown:

Validation of a Budget Impact Model for stent-based mechanical thrombectomy for acute ischaemic stroke

2022

Journal Article

Exercise in preventing falls for men with prostate cancer: a modelled cost-utility analysis

Edmunds, Kim, Scuffham, Paul, Newton, Robert U., Galvão, Daniel A. and Tuffaha, Haitham (2022). Exercise in preventing falls for men with prostate cancer: a modelled cost-utility analysis. Supportive Care in Cancer, 30 (6), 5037-5046. doi: 10.1007/s00520-022-06900-2

Exercise in preventing falls for men with prostate cancer: a modelled cost-utility analysis

2021

Journal Article

Demonstrating the value of early economic evaluation alongside clinical trials: Exercise medicine for men with metastatic prostate cancer

Edmunds, Kim, Scuffham, Paul, Reeves, Penny, Galvão, Daniel A., Taaffe, Dennis R., Newton, Robert U., Spry, Nigel, Joseph, David and Tuffaha, Haitham (2021). Demonstrating the value of early economic evaluation alongside clinical trials: Exercise medicine for men with metastatic prostate cancer. European Journal of Cancer Care, 30 (5) e13479, e13479. doi: 10.1111/ecc.13479

Demonstrating the value of early economic evaluation alongside clinical trials: Exercise medicine for men with metastatic prostate cancer